Potential Active Targeting of Gatifloxacin to Macrophages by Means of Surface-Modified PLGA Microparticles Destined to Treat Tuberculosis

  1. Marcianes, P.
  2. Negro, S.
  3. Barcia, E.
  4. Montejo, C.
  5. Fernández-Carballido, A.
Revista:
AAPS PharmSciTech

ISSN: 1530-9932

Ano de publicación: 2020

Volume: 21

Número: 1

Tipo: Artigo

DOI: 10.1208/S12249-019-1552-3 GOOGLE SCHOLAR